$LPTN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Apollo Endosurgery, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Apollo Endosurgery, Inc.. Get notifications about new insider transactions in Apollo Endosurgery, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Option Exercise | A | 8.86 | 5,271 | 46,701 | 51,124 | |
Jun 21 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Grant | A | 0.00 | 3,888 | 0 | 29,858 | 26 K to 29.9 K (+14.97 %) |
Jun 21 2021 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Option Exercise | A | 8.86 | 5,271 | 46,701 | 57,965 | |
Jun 21 2021 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Grant | A | 0.00 | 3,888 | 0 | 21,797 | 17.9 K to 21.8 K (+21.71 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.96 | 790 | 5,498 | 0 | 790 to 0 (-100.00 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.93 | 600 | 4,158 | 790 | 1.4 K to 790 (-43.17 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.92 | 3,400 | 23,528 | 1,390 | 4.8 K to 1.4 K (-70.98 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.91 | 5,524 | 38,171 | 4,790 | 10.3 K to 4.8 K (-53.56 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.90 | 3,144 | 21,694 | 10,314 | 13.5 K to 10.3 K (-23.36 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.89 | 464 | 3,197 | 13,458 | 13.9 K to 13.5 K (-3.33 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.88 | 1,100 | 7,568 | 13,922 | 15 K to 13.9 K (-7.32 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.85 | 20 | 137 | 15,022 | 15 K to 15 K (-0.13 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.81 | 500 | 3,405 | 15,042 | 15.5 K to 15 K (-3.22 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.80 | 600 | 4,080 | 15,542 | 16.1 K to 15.5 K (-3.72 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.73 | 600 | 4,038 | 16,142 | 16.7 K to 16.1 K (-3.58 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.72 | 300 | 2,016 | 16,742 | 17 K to 16.7 K (-1.76 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.71 | 100 | 671 | 17,042 | 17.1 K to 17 K (-0.58 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.70 | 800 | 5,360 | 17,142 | 17.9 K to 17.1 K (-4.46 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.67 | 200 | 1,334 | 17,942 | 18.1 K to 17.9 K (-1.10 %) |
May 20 2021 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Sell | S | 6.64 | 600 | 3,984 | 18,142 | 18.7 K to 18.1 K (-3.20 %) |
Apr 13 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 5.48 | 303 | 1,661 | 402,580 | 402.3 K to 402.6 K (+0.08 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | A | 5.95 | 16,627 | 98,931 | 180,140 | |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Grant | A | 0.00 | 14,028 | 0 | 95,907 | 81.9 K to 95.9 K (+17.13 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.92 | 2,600 | 15,392 | 25,970 | 23.4 K to 26 K (+11.13 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.91 | 600 | 3,546 | 23,370 | 22.8 K to 23.4 K (+2.64 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.90 | 3,000 | 17,700 | 22,770 | 19.8 K to 22.8 K (+15.17 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.89 | 1,500 | 8,835 | 19,770 | 18.3 K to 19.8 K (+8.21 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.87 | 100 | 587 | 18,270 | 18.2 K to 18.3 K (+0.55 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.85 | 2,100 | 12,285 | 18,170 | 16.1 K to 18.2 K (+13.07 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Buy | P | 5.84 | 100 | 584 | 16,070 | 16 K to 16.1 K (+0.63 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Option Exercise | A | 5.95 | 11,876 | 70,662 | 241,428 | |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Grant | A | 0.00 | 10,020 | 0 | 77,347 | 67.3 K to 77.3 K (+14.88 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | McKhann Chas | President and CEO | Option Exercise | A | 5.95 | 848,733 | 5,049,961 | 848,733 | |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | McKhann Chas | President and CEO | Grant | A | 0.00 | 707,278 | 0 | 707,278 | 0 to 707.3 K |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Option Exercise | A | 5.95 | 16,627 | 98,931 | 185,809 | |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Grant | A | 0.00 | 14,028 | 0 | 102,869 | 88.8 K to 102.9 K (+15.79 %) |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Option Exercise | A | 5.95 | 16,627 | 98,931 | 159,049 | |
Mar 12 2021 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Grant | A | 0.00 | 14,028 | 0 | 75,399 | 61.4 K to 75.4 K (+22.86 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 2,017 | 0 | 134,394 | 132.4 K to 134.4 K (+1.52 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 6,055 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 6,055 | 0 | 6,055 | 0 to 6.1 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 605,712 | 0 | 605,712 | 1.2 M to 605.7 K (-50.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 4,444 | 0 | 132,377 | 127.9 K to 132.4 K (+3.47 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 13,473 | 0 | 0 | 13.5 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 13,473 | 0 | 13,473 | 0 to 13.5 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 1,347,565 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 1,221,464 | 363.5 K to 1.2 M (+236.03 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 127,933 | 985.9 K to 127.9 K (-87.02 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 985,897 | 127.9 K to 985.9 K (+670.64 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 0 | 858 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 857,964 | 0 to 858 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 0 | 858 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 2,017 | 0 | 134,394 | 132.4 K to 134.4 K (+1.52 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 6,055 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 6,055 | 0 | 6,055 | 0 to 6.1 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 605,712 | 0 | 605,712 | 1.2 M to 605.7 K (-50.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 4,444 | 0 | 132,377 | 127.9 K to 132.4 K (+3.47 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 13,473 | 0 | 0 | 13.5 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 13,473 | 0 | 13,473 | 0 to 13.5 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 1,347,565 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 1,221,464 | 363.5 K to 1.2 M (+236.03 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 127,933 | 985.9 K to 127.9 K (-87.02 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 985,897 | 127.9 K to 985.9 K (+670.64 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 0 | 858 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 857,964 | 0 to 858 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 0 | 858 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 6,055 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 6,055 | 0 | 6,055 | 0 to 6.1 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 605,712 | 0 | 605,712 | 1.2 M to 605.7 K (-50.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 13,473 | 0 | 0 | 13.5 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 13,473 | 0 | 13,473 | 0 to 13.5 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 1,347,565 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 0 | 858 K to 0 (-100.00 %) |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 857,964 | 0 | 857,964 | 0 to 858 K |
Mar 09 2021 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 857,964 | 0 | 0 | 858 K to 0 (-100.00 %) |
Feb 24 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.62 | 4,166 | 19,230 | 26,446 | 22.3 K to 26.4 K (+18.70 %) |
Feb 24 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.62 | 8,055 | 37,182 | 402,277 | 394.2 K to 402.3 K (+2.04 %) |
Feb 24 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.80 | 10,103 | 48,524 | 394,222 | 384.1 K to 394.2 K (+2.63 %) |
Feb 22 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.75 | 1,649 | 7,830 | 384,119 | 382.5 K to 384.1 K (+0.43 %) |
Feb 22 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.75 | 378 | 1,795 | 22,280 | 21.9 K to 22.3 K (+1.73 %) |
Feb 08 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 5.14 | 15,488 | 79,630 | 116,360 | 100.9 K to 116.4 K (+15.35 %) |
Feb 08 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.71 | 30,954 | 145,861 | 382,470 | 351.5 K to 382.5 K (+8.81 %) |
Feb 08 2021 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | P | 4.84 | 7,101 | 34,344 | 21,902 | 14.8 K to 21.9 K (+47.98 %) |
Jan 07 2021 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | J | 0.00 | 3,479 | 0 | 412,306 | 408.8 K to 412.3 K (+0.85 %) |
Jan 07 2021 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Buy | J | 0.00 | 218 | 0 | 81,879 | 81.7 K to 81.9 K (+0.27 %) |
Dec 17 2020 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | S | 4.16 | 8,314 | 34,613 | 351,043 | 342.7 K to 351 K (+2.43 %) |
Dec 17 2020 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | S | 4.16 | 2,488 | 10,358 | 14,656 | 12.2 K to 14.7 K (+20.45 %) |
Dec 17 2020 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | S | 1.65 | 9,663 | 15,944 | 1,200,769 | 1.2 M to 1.2 M (+0.81 %) |
Dec 17 2020 | LPTN | Apollo Endosurgery ... | Gagnon Neil | 10% Owner | Buy | S | 1.65 | 693 | 1,143 | 52,027 | 51.3 K to 52 K (+1.35 %) |
Jul 21 2020 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Buy | P | 1.25 | 1,200,000 | 1,500,000 | 1,707,208 | 507.2 K to 1.7 M (+236.59 %) | |
Jul 21 2020 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Buy | P | 1.25 | 400,000 | 500,000 | 415,244 | 15.2 K to 415.2 K (+2,623.98 %) | |
Jul 21 2020 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Buy | P | 1.25 | 180,000 | 225,000 | 477,120 | 297.1 K to 477.1 K (+60.58 %) | |
Jul 21 2020 | LPTN | Apollo Endosurgery ... | CPMG Inc | Buy | P | 1.25 | 1,200,000 | 1,500,000 | 1,707,208 | 507.2 K to 1.7 M (+236.59 %) | |
Jul 21 2020 | LPTN | Apollo Endosurgery ... | CPMG Inc | Buy | P | 1.25 | 400,000 | 500,000 | 415,244 | 15.2 K to 415.2 K (+2,623.98 %) | |
Jul 21 2020 | LPTN | Apollo Endosurgery ... | CPMG Inc | Buy | P | 1.25 | 180,000 | 225,000 | 477,120 | 297.1 K to 477.1 K (+60.58 %) | |
Jun 18 2020 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 245,444 | 0 | 0 | 245.4 K to 0 (-100.00 %) |
Jun 18 2020 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 245,444 | 0 | 245,444 | 0 to 245.4 K |
Jun 18 2020 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 1,341,222 | 0 | 857,964 | 2.2 M to 858 K (-60.99 %) |
Jun 17 2020 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | J | 0.00 | 74,218 | 0 | 127,933 | 53.7 K to 127.9 K (+138.17 %) |
Jun 17 2020 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Sell | J | 0.00 | 245,444 | 0 | 0 | 245.4 K to 0 (-100.00 %) |
Jun 17 2020 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | J | 0.00 | 245,444 | 0 | 245,444 | 0 to 245.4 K |
Jun 17 2020 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Sell | J | 0.00 | 1,341,222 | 0 | 857,964 | 2.2 M to 858 K (-60.99 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | A | 2.08 | 62,718 | 130,453 | 163,513 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Grant | A | 0.00 | 42,000 | 0 | 81,661 | 39.7 K to 81.7 K (+105.90 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Option Exercise | A | 2.08 | 28,446 | 59,168 | 61,111 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Grant | A | 0.00 | 10,257 | 0 | 21,137 | 10.9 K to 21.1 K (+94.27 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Option Exercise | A | 2.08 | 29,317 | 60,979 | 45,853 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Grant | A | 0.00 | 10,571 | 0 | 15,970 | 5.4 K to 16 K (+195.80 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Option Exercise | A | 2.08 | 27,749 | 57,718 | 59,439 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Grant | A | 0.00 | 10,006 | 0 | 18,742 | 8.7 K to 18.7 K (+114.54 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Option Exercise | A | 2.08 | 28,156 | 58,564 | 52,694 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Grant | A | 0.00 | 10,153 | 0 | 17,909 | 7.8 K to 17.9 K (+130.91 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Option Exercise | A | 2.08 | 59,728 | 124,234 | 169,182 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Grant | A | 0.00 | 39,997 | 0 | 88,841 | 48.8 K to 88.8 K (+81.89 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Option Exercise | A | 2.08 | 61,949 | 128,854 | 142,422 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Grant | A | 0.00 | 41,485 | 0 | 61,371 | 19.9 K to 61.4 K (+208.61 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Option Exercise | A | 2.08 | 51,610 | 107,349 | 229,552 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Grant | A | 0.00 | 34,561 | 0 | 67,327 | 32.8 K to 67.3 K (+105.48 %) |
May 11 2020 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Option Exercise | A | 2.08 | 115,094 | 239,396 | 511,604 | |
May 11 2020 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Grant | A | 0.00 | 77,075 | 0 | 408,827 | 331.8 K to 408.8 K (+23.23 %) |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | Traweek James W JR | Buy | J | 0.00 | 38,108 | 0 | 507,208 | 469.1 K to 507.2 K (+8.12 %) | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | Traweek James W JR | Buy | J | 0.00 | 15,244 | 0 | 15,244 | 0 to 15.2 K | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | Traweek James W JR | Buy | J | 0.00 | 3,811 | 0 | 297,120 | 293.3 K to 297.1 K (+1.30 %) | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Buy | J | 0.00 | 38,108 | 0 | 507,208 | 469.1 K to 507.2 K (+8.12 %) | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Buy | J | 0.00 | 15,244 | 0 | 15,244 | 0 to 15.2 K | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Buy | J | 0.00 | 3,811 | 0 | 297,120 | 293.3 K to 297.1 K (+1.30 %) | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | CPMG Inc | Buy | J | 0.00 | 38,108 | 0 | 507,208 | 469.1 K to 507.2 K (+8.12 %) | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | CPMG Inc | Buy | J | 0.00 | 15,244 | 0 | 15,244 | 0 to 15.2 K | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | CPMG Inc | Buy | J | 0.00 | 3,811 | 0 | 297,120 | 293.3 K to 297.1 K (+1.30 %) | |
Jan 06 2020 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Buy | J | 0.00 | 206 | 0 | 39,661 | 39.5 K to 39.7 K (+0.52 %) |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Option Exercise | A | 3.27 | 16,536 | 54,073 | 32,665 | |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Grant | A | 0.00 | 5,399 | 0 | 10,880 | 5.5 K to 10.9 K (+98.50 %) |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Option Exercise | A | 3.27 | 16,536 | 54,073 | 16,536 | |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | BARR JOHN R | Director | Grant | A | 0.00 | 5,399 | 0 | 5,399 | 0 to 5.4 K |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Grant | A | 3.27 | 5,399 | 17,655 | 8,736 | 3.3 K to 8.7 K (+161.79 %) |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Option Exercise | A | 3.27 | 16,536 | 54,073 | 24,538 | |
Aug 20 2019 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Grant | A | 0.00 | 5,399 | 0 | 7,756 | 2.4 K to 7.8 K (+229.06 %) |
Aug 14 2019 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Option Exercise | J | 0.00 | 1 | 0 | 1 | |
Aug 14 2019 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 1,580,518 | 2.6 M to 1.6 M (-38.75 %) |
May 14 2019 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Grant | A | 3.54 | 3,600 | 12,750 | 321,268 | 317.7 K to 321.3 K (+1.13 %) |
May 14 2019 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | P | 3.53 | 25,000 | 88,350 | 317,668 | 292.7 K to 317.7 K (+8.54 %) |
May 10 2019 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Option Exercise | A | 3.49 | 30,973 | 108,096 | 80,473 | |
May 10 2019 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Grant | A | 0.00 | 19,886 | 0 | 19,886 | 0 to 19.9 K |
May 10 2019 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Option Exercise | A | 3.49 | 30,973 | 108,096 | 109,454 | |
May 10 2019 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Grant | A | 0.00 | 19,886 | 0 | 48,844 | 29 K to 48.8 K (+68.67 %) |
May 10 2019 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | A | 3.49 | 30,973 | 108,096 | 100,795 | |
May 10 2019 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Grant | A | 0.00 | 19,886 | 0 | 39,455 | 19.6 K to 39.5 K (+101.62 %) |
May 10 2019 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Option Exercise | A | 3.49 | 25,442 | 88,793 | 177,942 | |
May 10 2019 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Grant | A | 0.00 | 16,335 | 0 | 32,766 | 16.4 K to 32.8 K (+99.42 %) |
May 10 2019 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Option Exercise | A | 3.49 | 48,673 | 169,869 | 396,510 |